Absence of Kaposi sarcoma among ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus8

Mayo Clinic Proceedings

Volumn 77, Issue 9, 2002, Pages 905-909

  Grossman, Zehava ^a   Iscovich, Jose ^b   Schwartz, Fidi ^c   Azizi, Esther ^a   Klepfish, Avraham ^d   Schattner, Ami ^d   Sarid, Ronit ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b International Institute of Fertility   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CHILD; ETHIOPIA; ETHNIC GROUP; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; ISRAEL; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; VIRUS INFECTION;

EID: 0036729667     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.9.905     Document Type: Article

References (34)

1. Epidemiology of Kaposi's sarcoma
2. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
3. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
4. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
5. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
6. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIVinfected individuals and progression to Kaposi's sarcoma
7. Kaposi's sarcoma
8. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8
9. Kaposi's sarcoma-associated herpesvirus: Epidemiology, virology, and molecular biology
10. Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma
11. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
12. Cancer incidence in Jewish migrants to Israel, 1961-1981
13. Statistical methods in cancer research, vol II: The design and analysis of cohort studies
14. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: A population based incidence study
15. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel
16. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel
17. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81
18. Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe
19. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy
20. Sexual transmission and the natural history of human herpesvirus 8 infection
21. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985
22. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
23. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa
24. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa
25. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda
26. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997
27. Kaposi's sarcoma diagnosed in the Department of Pathology, Addis Ababa University Medical Faculty: A 15 years retrospective review of biopsy results 1981-1994
28. Cancer in southern Ethiopia
29. Dermatology in south western Ethiopia: Rationale for a community approach
30. Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: Association between clinical stages and laboratory markers
31. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8